TrianglePUBLICATIONS · 30569607
Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Med
- Publication date
- 2019 Jan
- First author
- Zhukova N
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Zhukova N
- type
- Author
- name
- Rajagopal R
- type
- Author
- name
- Lam A
- type
- Author
- name
- Coleman L
- type
- Author
- name
- Shipman P
- type
- Author
- name
- Walwyn T
- type
- Author
- name
- Williams M
- type
- Author
- name
- Sullivan M
- type
- Author
- name
- Campbell M
- type
- Author
- name
- Bhatia K
- type
- Author
- name
- Gottardo NG
- type
- Author
- name
- Hansford JR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Zhukova N
- type
- Author
- name
- Rajagopal R
- type
- Author
- name
- Lam A
- type
- Author
- name
- Coleman L
- type
- Author
- name
- Shipman P
- type
- Author
- name
- Walwyn T
- type
- Author
- name
- Williams M
- type
- Author
- name
- Sullivan M
- type
- Author
- name
- Campbell M
- type
- Author
- name
- Bhatia K
- type
- Author
- name
- Gottardo NG
- type
- Author
- name
- Hansford JR
- type
- Author
- bibliography ids
- nci-bib-e02a8217e058d1fdc14f4e4a
- book metadata
- content sha256
- a13068ba3495a03167fc5bf9b69dd4f5c467268f2222b08091ebbb3a6af449e7
- document type
- citation
- dois
- 10.1002/cam4.1799
- electronic publication date
- display
- 2018 Dec 19
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30569607
- immutable id
- pubmed:30569607@a13068ba3495a03167fc5bf9b69dd4f5c467268f2222b08091ebbb3a6af449e7
- journal
- abbreviation
- Cancer Med
- issn electronic
- 2045-7634
- issn print
- Source null
- issue
- 1
- name
- Cancer medicine
- nlm unique id
- 101595310
- pages
- 40-50
- volume
- 8
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30569607
- provenance
- batch id
- e808962322f3afebc564
- provider
- NCBI PubMed ESummary
- record sha256
- 11340c5afededbb65192eaef37eb99a0eb34cf34da97a1caebae55f555f6fb4c
- response sha256
- 3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
- retrieved at
- 2026-09-09T23:47:41.002093+00:00
- publication date
- display
- 2019 Jan
- precision
- month
- year
- 2019
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma.
Preserved source evidence · Not medical advice